MIRACEL (docetaxel anhydrous)

MIRACEL (docetaxel anhydrous)

MIRACEL (docetaxel anhydrous)

MIRACEL (docetaxel anhydrous)

MIRACEL (docetaxel anhydrous)

MIRACEL

MIRACEL

Description

MIRACEL (Docetaxel) belongs to the group of taxanes - a class of anticancer agents used in cancer chemotherapy. It is used for treating breast cancer, head and neck cancer, stomach cancer, prostate cancer and non-small-cell lung cancer.
Docetaxel appears twice as active in depolymerization inhibition as paclitaxel. It has incomplete cross-resistance with paclitaxel and do not have cross-resistance with fluorouracil và cisplatin.

Indications

• Breast cancer
• Non-small-cell lung cancer
• Prostate cancer
• Stomach cancer
• Head and neck cancer

Contraindications

Docetaxel is contra-indicated in patients who have a history of severe hypersensitivity reactions to docetaxel or one of the other ingredients of the product. 
Docetaxel should not be used in patients who have a neutrophilic granulocyte count of <1500/mm3.
Storage, shelf-life and packing units
Storage:  Store the vials in dry place below 30oC, protect from light. 
Shelf life:  24 months from manufacturing date. Do not use the drug after the expired date.
Package: Miracel 20mg/mL Vial 1ml; 4ml; 8ml

 

Related products

Current product

CALITAXEL

Current product

EMILOX

Current product

NECROVI

Current product

GLURINAX 600